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correlation between concentration of these cytokines in pleural ﬂuid 
and a number of resected mediastinal lymph nodes was found (for IL-
6: Spearman test: r=-0.723; p<0.001; for IL-1ra: r=-0.768; p<0.001). 
Number of “positive” N2 lymph nodes did not correlate with concen-
tration of IL-1ra and IL-6 in pleural ﬂuid. 
Conclusions: Systematic lymphadenectomy of the right mediastinum 
results in decrease of peripheral blood lymphocytes. The number of 
resected mediastinal lymph nodes negatively correlates with concentra-
tion of IL-6 and IL-1ra in pleural ﬂuid on postoperative day 1, regard-
less the pathological status of these lymph nodes. 
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Objectives: To assess changes of interleukin 6 (IL-6) and interleukin 
1 receptor antagonist (IL-1ra) in serum, sputum and pleural ﬂuid of 
patients operated on due to lung cancer. 
Methods: 38 patients treated with lobectomy or pneumonectomy, 
including 15 with complications and 23 without complications were 
analyzed. Serum IL-6 and IL-1ra concentration was measured before, 
at the end of surgery, and on postoperative day 1, 3, and 7 by ELISA 
test. Concentration of IL-6 and IL-1ra was also measured in sputum at 
the end of surgery and in drained pleural ﬂuid on postoperative day 1. 
Results: In the entire group, serum concentrations of IL-6 and IL-1ra 
were signiﬁcantly elevated after surgery (for IL-6: 6.38 (range: 3.33-
16.9) vs. 73.89 (30.9-196.8); 211.9 (141.6-344.65); 95 (53.4-192.6) 
and 34.4 (16-61.99) pg/mL; for IL-1ra: 468.75 (271.75-568.2) vs. 996 
(457.5-1641.5); 1260 (796.5-1899.5); 1144.6 (770.2-1878.5) and 913.1 
(431.5-1712.5) pg/mL). No signiﬁcant differences of serum concentra-
tions of IL-6 and IL-1ra between patients with and without complica-
tions were found. Patients with complications had higher concentration 
of IL-6 in drained ﬂuid (90048 (33490-94768) vs. 6554.4 (2003-20636) 
pg/mL; p=0.00006) and in sputum (3509.4 (2434-14168) vs. 367.6 
(245.8-1096) pg/mL, p=0.02). Patients with complications had higher 
concentration of IL-1ra in drained ﬂuid (67908 (52638-106694) vs. 
16950 (16050-45470) pg/mL; p=0.00007) and in sputum (80109 
(52289-212459) vs. 11816.3 (5854-30511.9) pg/mL, p=0.02). On day 
1 after surgery signiﬁcant correlation between serum and drained ﬂuid 
concentration for IL-6 as well as for IL-1ra were observed (Spear-
man test for IL-6: r=0.47; p=0.02; for IL-1ra: r=0.48; p=0.02) Logistic 
regression analysis showed that increase of concentration of IL-6 in 
pleural ﬂuid by 1000 pg/mL results in 3% increase of risk of complica-
tions (p=0.0008). Logistic regression analysis showed that increase of 
IL-1ra in pleural ﬂuid by 10000 pg/mL results is 21% increase of risk 
of complications (p=0.03). Results of multivariate analysis conﬁrmed 
that concentrations of IL-6 and IL-1ra in pleural ﬂuid on postoperative 
day 1 are independent risk factors of development of postoperative 
complications (for IL-6: OR=1.029; CI=1.002-1.058; p=0.036; for IL-
1ra: OR=1.024; CI=1.000-1.049; p=0.046). 
Conclusions: Elevated serum IL-6 and IL-1ra concentrations accom-
pany developed postoperative complications. Elevated concentration 
of IL-6 and IL-1ra in sputum, as well as elevated concentration of IL-6 
and IL-1ra in drained pleural ﬂuid on postoperative day 1 are promising 
early markers of postoperative complications. 
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Objective: With an extension of the average length of life, physicians 
are more often performing lung cancer surgery on the very elderly (pa-
tients more than 80 years old, or octogenarians). Our objective was to 
investigate potential problems from a postoperative course and review 
actions to be taken for better results.
Subjects and Methods: From 1998 to 2006, there were 30 octogenar-
ians (5.5%) of clinical stage 1 and stage 2 among 543 patients who 
were operated on for lung cancer. There were 22 males and 8 females; 
24 patients were aged from 80 to 82 years old, 3 patients were from 
83 to 85 years old and 3 patients were over 85 years old. Fourteen 
patients were heavy smokers and the smoking index was between 400 
and 2400 (mean±}S.D. 1140±}590). The operative methods were one 
pneumonectomy, 22 lobectomies, 2 segmental resections and 5 partial 
resections. The pathological ﬁndings showed 8 cases of squamous cell 
carcinoma, 20 of adenocarcinoma and 2 of LCNEC, and their patho-
logical stages were 22 patients of stage 1, 4 of stage 2 and 4 of stage 
3. Twenty-seven patients (90%) had an underlying disease, and almost 
all of those were circulatory system diseases (17 patients). Respiratory 
rehabilitation was performed in 21 patients. We analyzed their postop-
erative complications, quality of life, survival period, and discussed the 
problems with lung surgery for octogenarian patients. 
Results: 1) Postoperative acute phase progress: All patients could get 
out of bed at an early postoperative day; 24 patients could walk within 
2 days, and 6 patients between 2 days and 5 days. As for the postopera-
tive complications, 6 patients had a cardiac arrhythmia, one patient 
had difﬁculty in mucus expectoration, and 5 patients had postoperative 
disorientation (17%), among which 2 patients fell from the bed in the 
night. All of the patients recovered well and were discharged from the 
hospital, but one patient died from pneumonia within 3 months after 
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discharge. 2) Postoperative chronic stage progress: The postoperative 
survival rate by Kaplan-Meyer was 91% for 2 years and 66% for 5 
years. Five patients (17%) died of recurrence, and 2 of those 5 patients 
died within one year. Three patients (10%) who died by other disease, 
and 2 patients who died due to unknown causes due to the fact that they 
were lost to the clinical follow-up.
Conclusions: Postoperative survival of an octogenarian with stage 1 
or stage 2 lung cancer was anticipated by the control of the underly-
ing disease before surgery. However, we should pay attention for the 
postoperative psychosomatic ageing progress. 
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Background: Stage I non-small cell lung cancer (NSCLC) includes 
stage IA (T1N0) and stage IB (T2N0), which classiﬁcation including 
tumors greater than 3.0 cm in greatest diameter. There are many reports 
on tumor size and survival for patients with T1 or T2 category NSCLC. 
The objective of this study was to evaluate the relationship between 
tumor size and survival in patients with stage I NSCLC.
Methods: There were 281 patients with stage I NSCLC by retrospec-
tive review of lung cancer database from January 1996 to December 
2005. All cases with peripheral tumors were completely resected with 
lymph nodes dissection. T2 factor deﬁned as greater than 3.0 cm in 
greatest diameter. The other T2 factors were excluded such as visceral 
pleura invasion, involving the mainstem bronchus but are greater than 
or equal to 2.0 cm distal from carina, and tumors that result in atelec-
tasis or lobar collapse radiographically. There were 192 men and 89 
women with median age of 66.9 ranging 42 to 84 years. Histologic type 
was adenocarcinoma in 178, squamous cell carcinoma in 78 (27.9%), 
and other histologic types in 24 (8.5%). Stage IA was in 164 and IB in 
117. We sub-classiﬁed by greatest diameter as ≤2.0 cm (n=81), 2.1-3.0 
cm (n=83), 3.1-5.0 cm (n=93), and >5.0 cm (n=24). Additionally, we 
also sub-classiﬁed by greatest diameter as ≤2.0 cm (n=81), 2.1-5.0 cm 
(n=176), and >5.0 cm (n=24). The survival curves were estimated by 
the Kaplan-Meier method, and the difference in survival was tested by 
the log-rank test.
Results: The 5-year survival rate was 79.6% for stage IA and 75.1% 
for stage IB, which was statistically signiﬁcant (p=0.0186). The 5-year 
survival rate for tumor size of ≤2.0 cm, 2.1-3.0 cm, 3.1-5.0 cm, and 
>5.0 cm was 89.7%, 71.8%, 78.6%, and 24%, respectively (0.0007). 
The 5-year survival rate for tumor size of ≤2.0 cm, 2.1-5.0 cm, and 
>5.0 cm was 89.7%, 75.9%, and 24%, respectively (0.0002).
Conclusions: Tumor size inﬂuenced survival for surgically resected 
patients with stage I NSCLC. Cases with tumor size greater than 5.0 cm 
showed signiﬁcantly poor prognosis. There is signiﬁcant heterogeneity 
in the T2N0 NSCLC.
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Background: The frequency of incomplete bronchial resection margins 
is small (range 1.2-5.4%). Whether incomplete microscopic resection 
margins is relevant or not is matter of debate. Since the routine proce-
dure is to achieve local cure with frozen examination of the bronchial 
resection margin, and if necessary perform additional surgery the ques-
tion rises whether this inﬂuences the prognosis of these patients. 
Methods: In a retrospective multicenter case control study patients 
who received a surgical treatment for primary pulmonary carcinoma 
before December 31, 2001 were selected and divided into three groups 
based on the following criteria: patients with a tumor positive bronchial 
resection margin at intra-operative frozen section procedure (VC+); 
patients with tumor negative frozen section analysis (VC-) and cases 
where no intra-operative bronchial resection margin analysis was per-
formed (noVC). The cases for VC- and noVC were matched for prior 
date of operation to a case in group VC+. 
Results: The total number of cases was for VC+, VC- and noVC group 
31, 31 and 25, respectively. Age and gender was not different between 
these groups. Age of men (n=72, 64 ± 8 yrs) and women (n=15, 60 ± 9 
yrs) was not signiﬁcantly different, p=0.10.
The initial tumor positive frozen section margin was due to direct 
tumor invasion (n=15), combined direct tumor invasion and carci-
noma in situ (n=6), carcinoma in situ alone (n=6), lymfangitic spread 
peribronchial (n=3), lymfangitic spread mucosal (n=1), perineural 
growth (n=3). More patients died of disease when the combined direct 
tumor invasion and carcinoma in situ was present in the intial frozen 
section compared to only direct tumor invasion or only carcinoma in 
situ (p=0.48).
The distance from the tumor to the presumed resection margin was 
signiﬁcantly shorter for VC+ then in noVC on CT scan (p=0.01), X-ray 
(p<0.01) and on information obtained during bronchoscopy.(p=0.04). 
Distance between VC+ and VC- was not different. Within the VC+ and 
within the noVC group the distance estimation was slightly shorter for 
the bronchoscopy compared to the CT and X-ray group. Additional 
surgical resection in the VC+ lead to free surgical resection margins in 
most cases.
The mean follow-up was 3.7 years (range 0-12 years). In each group 
approximately 40% survived more than 5 years. Survival chance was 
not different between VC+, VC- and noVC, (p= 0.21). 
Conclusion: Patients with initial intraoperative positive resection mar-
gins and after extension free resection margins have a similar survival 
chance compared to those with initial tumor free resection margins or 
those with tumors at wider distance from resection margin.
